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Proliferating Cell Nuclear Antigen: A Marker
for Hepatocellular Proliferation in Rodents
by Sandra R. Eldridge,1 Byron E. Butterworth,2 and Thomas
L. Goldsworthy2
Two different markers for quantitating cell proliferation were evaluated in livers of control
and chemically treated mice and rats. Proliferating cell nuclear antigen (PCNA), an endogenous
cell replication marker, and bromodeoxyuridine (BrdU), an exogenously administered DNA pre-
cursor label, were detected in formalin-fixed, paraffin-embedded tissues using immunohisto-
chemical techniques. The percentage of cells in S phase (labeling indexes, LI) evaluated as
PCNA- or BrdU-positive hepatocellular nuclei was compared in recut tissue sections from ani-
mals given BrdU by a single IP injection 2 hr before killing the animals. Ten-week-old male
B6C3F, mice and F344 rats were exposed to known mitogenic hepatocarcinogens, Wy-14,643 (WY)
in the diet at 0.1% for 2 days or 1,4-dichlorobenzene (DCB) in corn oil by gavage for 2 days (600
mg/kg/day in mice; 300mg/kg/day in rats). Inmice, PCNA and BrdU hepatocyte LI were similar in
control, WY-treated, and DCB-treated animals. In rats, PCNA and BrdU gave similar LI in con-
trols and Wy-treated animals. Although PCNA LI was statistically lower than BrdU LI in DCB-
treated rats, both PCNA and BrdU LI for DCB-treated rats was increased over LI in control rats.
Different patterns of PCNA immunohistochemical staining, interpreted to represent different
subpopulations of cells at various phases of the cell cycle, were quantitated using PCNA
immunohistochemistry. The proliferating index (PI), defined as the percentage ofcells in the cell
cycle (GI + S + G2 + M), was more sensitive than the LI (S phase only) in detecting a chemically
induced cell proliferative response. Due to reports of adverse effects of BrdU on cell prolifera-
tion, PCNA immunohistochemical methods were used to determine the effect of duration of
exogenously administered DNA precursor label (BrdU or [3H]-thymidine [3H-TdRl) on rodent
hepatocyte proliferation measurements. PCNA LI were determined in control animals pulse
labeled with BrdU or 3H-Tdr, or labeled continuously for 3 or 6 days. PCNA LI did not increase
with duration of exposure to BrdU or 3H-Tdr, suggesting that these labeling conditions are not
causing a hepatocellular proliferative response. These results demonstrate comparable hepato-
cyte labeling ofcells in S phase in control and chemically treated mice and rats with PCNA and
pulse-BrdU labelingmethods, supporting the use ofPCNA as an alternative marker in either ret-
rospective orprospective cell proliferation studies.
Introduction
An increasing amount of evidence indicates that
chemically induced cell proliferation may play a key
role in chemical carcinogenesis (1-3). It has been postu-
lated that for nongenotoxic carcinogens, the induction
of cell proliferation in the target tissue is an important
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component of tumor formation (2). Understanding the
relationship between chemically induced cell prolifera-
tion and carcinogenic activity would be valuable in the
investigation ofmechanisms ofcarcinogenesis. Further-
more, this understanding might assist in the develop-
ment of assays for identifying nongenotoxic carcino-
gens, the selection of appropriate doses for cancer
bioassays, and the improvement of risk assessment
models. It has been difficult to formulate a comprehen-
sive database to relate chemically induced cell prolifer-
ation to carcinogenesis because quantitative studies in
which cell proliferation was measured are lacking.
Traditionally, chemically induced cell proliferation in
a target tissue has been quantitated by histoautoradi-
ographic visualization of [3H]thymidine (3H-Tdr) incor-
poration into the DNA ofcells in S phase. More recent-
ly, immunohistochemical techniques using a monoclonalELDRIDGE ETAL.
antibody to 5-bromo-2'-deoxyuridine (BrdU) have been
used to detect cells that have incorporated BrdU dur-
ing the S phase of the cell cycle. Both 3H-Tdr and
BrdU are administered exogenously via pulse dosing
or by surgically implanted osmotic pumps to identify
cells in S phase. However, a method to identify repli-
cating cells using an antibody that recognizes an
endogenous marker of cell replication, proliferating
cell nuclear antigen (PCNA), has been recently devel-
oped (4,5). PCNA is an auxiliary protein of DNA poly-
merase 6, an enzyme necessary for DNA synthesis (6).
Synthesis ofthis protein begins in the late G1 phase of
the cell cycle and peaks during S phase (7). Immuno-
histochemical detection of PCNA in formalin-fixed,
paraffin-embedded archival rodent tissues has been
achieved using a commercially available antigen
retrieval system based on microwave exposure of his-
tologic sections in the presence of heavy metal salts
(4,8). Furthermore, PCNA analysis has the potential to
identify cells in the different phases of the cell cycle
[i.e., G1, S, G2, and M (5)]. This type of analysis might
reveal potentially critical information on a chemical's
effect on individual cell cycle populations and the popu-
lation of proliferating cells. At present, the use and
interpretation of PCNA in cell proliferation studies
requires further validation.
One way to evaluate PCNA as a marker for cell
proliferation is to compare cell labeling indexes (LI,
percentage of cells in S phase) obtained with PCNA to
BrdU in the same animals. Similar LI have been
obtained with 3H-Tdrand BrdU in control and chemically
treated rodent liver and kidney (9,10). In the experi-
ments presented here, BrdU administered by IP injec-
tion was compared to PCNA for measuring hepa-
tocellular proliferation in control and chemically treated
mice and rats to evaluate the feasibility ofusing PCNA
immunohistostaining forcell proliferation studies.
Because PCNA is an endogenous marker ofreplicat-
ing cells, it gives an indication ofthe S phase portion of
cells at the particular point in time at which the animal
was killed. Thus, using PCNA immunohistochemical
methods to detect cells in S phase is expected to be
analogous to detecting S phase cells using a DNA pre-
cursor label administered by a single pulse injection.
PCNA, however, has the potential to identify the pro-
liferating cell pool, not just cells in S phase. Thus, the
proliferating index (percentage of cells cycling, PI)
obtained with PCNA should be greater than the S
phase LI obtained with PCNA or pulse BrdU. In the
present study, the sensitivity of PCNA to detect a
chemically induced cell proliferative response was
investigated by comparing PCNA PI to PCNA LI.
The pulse labeling method gives an indication ofthe
level ofLI at a specific point in time, whereas continu-
ous labeling via an implanted osmotic pump is cumula-
tive and labels all cells that enter S phase during the
period ofinfusion ofthe DNA precursor label.The deci-
sion whether to use pulse or pump label administration
depends on the experimental question and the
turnover rate of the target cell population. Recent
reports have suggested that continuous administration
of BrdU may induce cell proliferation secondary to
cumulative toxicity (11). IfBrdU administration affect-
ed the rate of cell proliferation, then the PCNA LI
might be expected to depend on the length ofexposure
to BrdU. To further investigate this hypothesis, we
used PCNA analysis on archival material to examine
the effect of duration of exogenously administered
DNA precursor on rodent hepatocyte proliferation
measurements.
Materials and Methods
Tissues
Archival material from a previously conducted cell
proliferation study (10) was used in these experiments.
The experimental design is outlined in Table 1. Briefly,
10-week-old male B6C3F1 mice and F344 rats were
exposed to either Wy-14,643 (WY) in the diet at 0.1%
for2, 4 or 5 days, or 1,4-dichlorobenzene (DCB) in corn
oil by gavage for 2, 4, or 5 days (600 mg/kg/day for
mice; 300 mg/kg/day for rats). Controls were included
at each time point.
Five animals per group received either BrdU or 3H-
Tdr administered by IP injection or continuously for 3
or 6 days by sc-implanted osmotic pumps. For IP injec-
tions, BrdU (100 mg/kg ofa 20 mg/mL solution) or 3H-
Tdr (2 mCi/kg) was administered 2 hr before killing
the animals. Osmotic pumps were implanted in animals
to deliver either BrdU or 3H-Tdr for 3 or 6 days (1
gL/hr for mice, 10 gL/hr for rats). BrdU and 3H-Tdr
were delivered at a rate of 20 jig/hr (65 nmole/hr) and
10gCi/hr (1.2 x 104 nmole/hr), respectively, in mice, or
200 gg/hr (650 nmole/hr) and 100 ggCi/hr (12 x 104
nmole/hr) in rats.
Sections of liver were fixed in 10% neutral-buffered
formalin for 4 days, embedded in paraffin, and stored
for 26 months before performing PCNA immunohisto-
chemistry. Liver sections were recut 4-5 4m thick from
the same tissue blocks that had been previously used
for BrdU immunohistochemistry or 3H-Tdr autoradi-
ography (10).
Table 1. Experimental design.
Day 2-hrpulsea 3-daypumpb 6-day pumpb
-1 Implant
0 Chemicale Chemical Chemical
1 Chemical Chemical/implant Chemical
2 Inject/sacrifice Chemical Chemical
3 Chemical Chemical
4 Sacrifice Chemical
5 Sacrifice
aSingle IPinjection ofBrdU of3H-Tdr administered 2 hrbefore
killing control and treated animals.
bOsmoticpumps containing BrdU or3H-Tdrimplanted in control
and treated animals; only controls used inthe present study.
c"Chemical"denotes VVY or DCB. Controls were included at each
time point.
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Immunohistochemistry
Previously described methods were followed for
PCNA immunohistochemistry (4). Briefly, tissue sec-
tions were mounted on 3-aminopropyltriethyloxysi-
lane-coated slides to ensure adhesion during process-
ing, deparaffinized in xylene, and passed through
graded alcohols. Endogenous peroxidase was inhibited
with 3% hydrogen peroxide (8 min). Slides were then
immersed in antigen-retrieval solution (BioGenex
Laboratories, San Ramon, CA) in a plastic Coplin jar
with a loose-fitting screw cap. The Coplin jar was
placed in a 720 W microwave oven set on the highest
power (10 min for mice and 5 min for rats). Distilled
water was added to prevent slide dehydration before
reheating in the microwave oven for the same dura-
tion. After cooling to room temperature, sections were
incubated for 1 hr at room temperature with the pri-
mary antibody, monoclonal anti-PCNA 19A2 (Coulter
Immunology, Hialeah, FL), at a dilution of 1:400 for 1
hr at room temperature. Subsequently, the slides were
incubated for 30 min at room temperature with
biotinylated goat anti-mouse IgM (Jackson Immuno-
logy Research Laboratory, West Grove, PA) diluted
1:200. Slides were then incubated with streptavidin
conjugated to horseradish peroxidase for 30 min at
room temperature. The PCNA was localized by a final
incubation with the chromagen 3-amino-9-ethylcar-
bazole (AEC; Zymed Laboratory, Inc., San Francisco,
CA). Tissue sections were counterstained with hema-
toxylin and coverslipped with Crystal mount (Biomeda
Corporation, Foster City, CA).
Scoring Labeled Hepatocytes
Positive staining for PCNA was categorized based
on cellular distribution and intensity of the red reac-
tion product that correlated with the different phases
of the cell cycle as reported by Foley et al. (5).
Computer-generated random fields were used to score
PCNA by light microscopy. At least 1000 hepatocellu-
lar nuclei in the left lobe were counted in at least 6
fields. Typically, 1500-2000 nuclei were counted in
PCNA-stained liver sections. Labeling index was cal-
culated by dividing the number ofhepatocyte nuclei in
S phase by the total number of hepatocyte nuclei
counted, and the results were expressed as a percent-
age. In addition, an index was calculated for G1, G2, or
M phase of the cell cycle. A proliferating index was
defined as the percentage of cells in the cell cycle, i.e.,
GI + S + G2 + M divided by G, + S + G2 + M + Go. The
PCNA LI was compared to the BrdU LI that had been
previously quantitated (10).
Statistical Analysis
The Student's t-test for the equality of two means
was used to test for significant differences between
PCNA and pulse BrdU LI, and LI for control and
chemically treated groups. The Student-Newman-
Keuls' test for the inequality ofunpaired multiple data
sets was used to determine significant differences in
PCNA LI between pulse-, 3-day, and 6-day pump-
labeled animal groups.
Results
Comparison ofPCNA to Pulse BrdU
Consistent PCNA staining was achieved in archival
liver tissue sections. Staining of PCNA antigen-anti-
body complexes was categorized based on the cellular
distribution and intensity of the reaction product,
which was interpreted as representing the different
phases of the cell cycle (Fig. 1). Uniform, dark red
nuclear staining was judged to be positive for S phase
cells. A cell in the GI phase ofthe cell cycle had diffuse,
stippled nuclear staining that was lighter than a cell in
S phase. Cells in the G2 phase exhibited distinct, dif-
fuse cytoplasmic stippling with or without nuclear
staining. Mitotic figures were conspicuous with diffuse
cytoplasmic stippling.
The percentage ofhepatocytes in S phase was gener-
ally similar for both PCNA and pulse-labeled BrdU in
control and treated mice and rats (Fig. 2). In rats, how-
ever, PCNA LI was statistically less than BrdU LI in
DCB-treated animals (Fig. 2B). Nevertheless, PCNA
LI in DCB-treated rats was significantly greater than
in control animals, as observed with BrdU.
Under the treatment regimen and at the time point
examined, the distribution of cells in each phase ofthe
cell cycle was altered in WY- and DCB-treated groups
as shown in Figure 3. In WY-treated mice, the per-
centage of hepatocytes in all phases of the cell cycle
was increased, whereas in DCB-treated mice only the
percentage of hepatocytes in the GI phase and S phase
was slightly increased (Fig. 3A). In WY- and DCB-
treated rats, the percentage ofhepatocytes in all phas-
es ofthe cell cycle was increased (Fig. 3B).
The proliferating index as detected by PCNA was a
more sensitive indicator of a chemically induced cell
proliferative response than LI detected by PCNA
(Fig. 4). The fold increase in cell proliferation of treat-
ed over control animals was greater for PI than LI.
Effects ofExogenous DNA Precursor
Label on Cell Proliferation as Detected
by PCNA
Comparable hepatocyte labeling of cells in S phase
was obtained with PCNA in control animals that
received either BrdU or 3H-Tdr by a 2 hr pulse, a 3-
day or 6-day pump (Fig. 5). PCNA LI did not differ
between 2 hr pulse-labeled and 3-day or 6-day pump-
labeled mice, regardless of the DNA precursor label
(Fig. 5A). In rats, the PCNA LI in 2-hr 3H-Tdr-labeled
animals was statistically greater than PCNA LI in 3-
day and 6-day pump-labeled rats (Fig. 5B). In BrdU-
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FIGURE 1. Immunohistochemical staining forproliferating cell nuclear antigen; GI, S, G2, and M phases ofthe cell cycle identified in rodent liver.
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FIGURE 2. PCNA and bromodeoxyuridine (BrdU) labeling indexes in the liver ofcontrol and WY- ordichlorobenzene-treated mice (A) and rats
(B). Test chemicals were administered for 2 days. BrdU was administered 2 hr before killing the animals. Liver sections stained for PCNA
were from the same tissue blocks used for BrdU immunohistochemistry. Value above each bar represents the mean ± SE of five animals.
Percentage ofhepatocytes in S phase was determined by counting at least 1000 nuclei as described in Materials and Methods. (*) BrdU and
PCNA differ significantly (Student's t-test,p < 0.05).
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FIGURE 3. G1, S, G2 and M phase indexes in the liver of control and WY- or dichlorobenzene-treated mice (A) and rats (B) stained by PCNA.
Test chemicals were administered for 2 days. Percentage of hepatocytes in each individual phase of the cell cycle was determined as
described in Materials and Methods. Value above each bar represents a total offive animals.
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labeled rats, PCNA LI did not differ among 2 hrpulse-,
3-day, or6-day pump-labeled animals.
Discussion
The data presented here support the hypothesis that
PCNA may serve as a valuable marker for hepatocyte
proliferation. Because PCNA is an endogenous marker
of proliferating cells, it can be used in retrospective
studies with archival tissues as well as prospective
studies. Under the conditions used in these experi-
ments, PCNA was similar to pulse BrdU in detecting
both background and chemically induced cell prolifera-
tion. The use of PCNA was validated in archival liver
tissues, with two species (mouse and rat) and for two
chemical carcinogens (WY and DCB) by comparison
with previous cell proliferation data gathered via con-
ventional BrdU and 3H-Tdr techniques. Thus, PCNA
would appear to provide a useful means for retrospec-
tive assessment of cell proliferation in previously con-
ducted rodent toxicity and carcinogenicity studies in
which animals were not administered an exogenous
DNA precursor label.
In only one instance was a statistically significant
difference in LI between PCNA and pulse BrdU
observed. Specifically, in DCB-treated rats, PCNA LI
was observed to be less than BrdU LI. However, this
difference was slight and was not considered to be bio-
logically significant. Furthermore, PCNA LI for DCB-
treated rats was increased over controls, suggesting
statistical ratherthan biological significance.
Not only was PCNA equally as sensitive as pulse
BrdU for detecting hepatocytes in S phase, but the PI
measured using PCNA was more sensitive than pulse-
label methodology orPCNA LI fordetecting an induced
cell proliferative response. Evidence for this is shown
by the fold increase over controls in chemically treated
groups, which was greater for PI than for PCNA LI.
Furthermore, PCNA detected a similar population of
replicating cells as observed by BrdU pump-labeled
animals (10). This was evident by the similar pattern of
hepatocellular labeling by PCNA and BrdU, which was
periportal in WY-treated rats and centrilobular in
DCB-treated mice that received 3-day pumps (10).
Whereas the pulse-labeling method did not label
enough cells to detect a pattern oflabeled cell distribu-
tion, PCNA immunostaining was able to detect these
patterns. This is to be expected because the PI detects
cells in the various stages of the cell cycle (G1, S, G2,
and M), and not only those in S phase. Thus, the PI
would allow for a larger window of observation in
which a proliferative effect may be observed and
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increase the chance to detect a specific peak ofinduced
proliferation in a target tissue. Furthermore, PI analy-
sis by PCNA has the potential to identify perturba-
tions in the cell cycle, such as a block at the G,/S phase
border, which may lead to an increased understanding
ofa chemical's effect on cell growth and kinetics.
Detection of different cell subpopulations based on
phases ofthe cell cycle using PCNA methodology may
reveal interesting information about the cell cycle, as
has been previously speculated. PCNA synthesis
begins in GI phase and peaks in S phase (7,12). During
G2 with dissolution of the nuclear membrane, PCNA
apparently leaks into the cytoplasm. The different
staining patterns and intensities were interpreted to
represent individual phases ofthe cell cycle as described
by Foley et al. (5). However, further characterization
studies are required to confirm this correlation and to
clarify the interpretation ofsuch data.
Immunohistochemical detection ofPCNA as an alter-
native method for identifying replicating cells has been
compared to autoradiographic procedures with 3H-Tdr
and immunohistochemical methods using BrdU or
other markers of cell proliferation. These studies have
revealed both positive and negative correlations
(12-16). Although the reasons for these discrepancies
are unknown and warrant further investigation, they
may be related to PCNA gene regulation (17), temporal
expression of PCNA as a function of the cell cycle in
different cell types (12,15), and/or differences between
target epitopes of the anti-PCNA antibody used.
Finally, cell cycle distribution for markers ofcell prolif-
eration differs. For example, BrdU and 3H-Tdr incorpo-
ration occurs only during the synthesis of DNA (S
phase). PCNA, however, has the potential to identify
various stages of the cell cycle (G,, S, G2, and M).
Therefore, investigators need to specify the character-
istics ofa positive response. The results presented here
indicate that only cells exhibiting distinct nuclear stain-
ing for PCNA should be scored as S phase cells to gen-
erate a labeling index. Comparisons of labeling index
generated using 3H-Tdr or flow cytometric analysis
versus PCNA have shown good correlations (13,14).
BrdU pump labeling methods are useful for assess-
ing chronic and/or low levels of chemically induced cell
proliferation over a period of time. Recent reports
have suggested that continuous administration of
BrdU may induce cell proliferation secondary to cumu-
lative toxicity (11). To further investigate this hypoth-
esis, we examined the effect ofduration ofexogenously
administered DNA precursor label on rodent hepato-
cyte proliferation measurements. To determine whether
any effects may be specific for BrdU or generalized for
DNA precursor labels, the PCNA LI was examined in
the liver of mice and rats following BrdU and 3H-Tdr
administration. If BrdU or 3H-Tdr affected cell prolif-
eration, then the PCNA LI would be expected to
depend on the length of exposure to BrdU or 3H-Tdr.
PCNA LI did not increase with duration of exposure
to BrdU or 3H-Tdr, suggesting that under these label-
ing conditions, an increased hepatocyte proliferative
response does not occur.
The data presented here further support the use of
PCNA immunohistochemical staining in cell prolifera-
tion studies. The ability to detect PCNA in archival
rodent tissues will permit retrospective cell prolifera-
tion studies to be conducted without repeating costly
rodent toxicity and carcinogenicity studies. The gener-
ation of such data will help clarify the extent to which
cell proliferation may be involved in chemically
induced carcinogenesis. Analysis of PI and chemically
induced cell cycle effects using PCNA immunostaining
has the potential to yield novel, important cell prolifer-
ation data and warrants further investigation.
We thank Otis Lyght for immunohistochemical staining and Julie
Foley and Robert Maronpot for helpful discussions.
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